Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis

NCT01125761 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Dermatitis

Interventions

DRUG: dexamethasone 0.5 mg and 1.0 mg clemastine cream
DRUG: Dexamethasone 0,5 mg cream

Sponsor

Azidus Brasil